DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE was reported 1783 times

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE PALLOR 1 0.3333
1 NEONATAL HYPERGLYCAEMIA 10 0.2703
2 TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIAL MONITORING ABNORMAL 7 0.2121
3 REEXPANSION PULMONARY OEDEMA 2 0.1667
4 NASOGASTRIC OUTPUT HIGH 2 0.1667
5 PHRENIC NERVE INJURY 3 0.1500
6 HEART RATE VARIABILITY DECREASED 4 0.0976
7 PARATONIA 2 0.0769
8 CANNABIS INTERACTION 1 0.0769
9 LUNG ASSIST DEVICE THERAPY 4 0.0645
10 TRIGEMINO-CARDIAC REFLEX 5 0.0617
11 INFANT IRRITABILITY 6 0.0612
12 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST 1 0.0588
13 BURKHOLDERIA TEST POSITIVE 7 0.0565
14 GLOSSOPTOSIS 12 0.0548
15 BEZOLD-JARISCH REFLEX 2 0.0526
16 HYPOCAPNIA 22 0.0526
17 MYOCARDIAL CALCIFICATION 6 0.0513
18 NEGATIVE PRESSURE PULMONARY OEDEMA 4 0.0408
19 FLOPPY IRIS SYNDROME 15 0.0408
20 IMMUNODEFICIENCY CONGENITAL 1 0.0400
21 ELECTROCARDIOGRAM R ON T PHENOMENON 2 0.0400
22 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 2 0.0364
23 HYPERCAPNIC COMA 5 0.0352
24 UPPER AIRWAY OBSTRUCTION 29 0.0327
25 NEONATAL DYSPNOEA 3 0.0316
26 POSTRESUSCITATION ENCEPHALOPATHY 2 0.0312
27 POSTOPERATIVE DELIRIUM 6 0.0303
28 MECHANICAL VENTILATION COMPLICATION 4 0.0268
29 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 2 0.0267
30 CATHETER SITE NECROSIS 1 0.0263
31 RENAL ISCHAEMIA 14 0.0256
32 PHAEOCHROMOCYTOMA CRISIS 5 0.0236
33 DIABETES INSIPIDUS 55 0.0228
34 FOETAL MEGACYSTIS 1 0.0227
35 SUBCAPSULAR SPLENIC HAEMATOMA 1 0.0222
36 PAROXYSMAL ATRIOVENTRICULAR BLOCK 1 0.0217
37 PUERPERAL PYREXIA 1 0.0200
38 WITHDRAWAL HYPERTENSION 4 0.0198
39 ACUTE MOTOR AXONAL NEUROPATHY 2 0.0192
40 NEONATAL HYPOTENSION 7 0.0190
41 ACQUIRED FACTOR V DEFICIENCY 2 0.0182
42 NEONATAL RESPIRATORY DEPRESSION 6 0.0181
43 ELECTROCARDIOGRAM T WAVE BIPHASIC 1 0.0179
44 SEDATIVE THERAPY 1 0.0175
45 VENTRICULAR ASYSTOLE 3 0.0172
46 IRREGULAR BREATHING 10 0.0170
47 SINUS ARREST 26 0.0166
48 INTESTINAL PSEUDO-OBSTRUCTION 14 0.0159
49 AGITATION POSTOPERATIVE 1 0.0159
50 AIRWAY COMPLICATION OF ANAESTHESIA 4 0.0152
51 HYPOTENSIVE TRANSFUSION REACTION 1 0.0152
52 HAPTOGLOBIN INCREASED 2 0.0146
53 CARDIAC ARREST NEONATAL 2 0.0145
54 PROCALCITONIN DECREASED 1 0.0143
55 SEIZURE LIKE PHENOMENA 22 0.0129
56 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 78 0.0128
57 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III 1 0.0127
58 HEART ALTERNATION 1 0.0125
59 FACTOR V DEFICIENCY 2 0.0125
60 ARTERIOSPASM CORONARY 50 0.0125
61 BACTERIAL TRACHEITIS 1 0.0123
62 RHYTHM IDIOVENTRICULAR 4 0.0123
63 NEONATAL CHOLESTASIS 1 0.0119
64 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
65 DELAYED RECOVERY FROM ANAESTHESIA 11 0.0116
66 EYELID EROSION 1 0.0115
67 ACQUIRED MACROGLOSSIA 1 0.0112
68 DRUG WITHDRAWAL CONVULSIONS 20 0.0112
69 INFANTILE APNOEA 9 0.0110
70 SEDATION COMPLICATION 28 0.0110
71 EXAGGERATED STARTLE RESPONSE 2 0.0109
72 PRODUCT APPEARANCE CONFUSION 10 0.0108
73 NEONATAL ANURIA 1 0.0105
74 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
75 HYPERTHERMIA MALIGNANT 15 0.0101
76 CARDIAC CIRRHOSIS 1 0.0097
77 CENTRAL SLEEP APNOEA SYNDROME 3 0.0092
78 REFRACTORINESS TO PLATELET TRANSFUSION 1 0.0092
79 PHRENIC NERVE PARALYSIS 2 0.0091
80 PERONEAL NERVE INJURY 1 0.0088
81 DRUG HALF-LIFE INCREASED 1 0.0088
82 ACQUIRED DIAPHRAGMATIC EVENTRATION 3 0.0085
83 CEREBROVASCULAR INSUFFICIENCY 2 0.0083
84 NASAL CAVITY MASS 1 0.0082
85 CALCIFICATION OF MUSCLE 1 0.0080
86 BRADYARRHYTHMIA 13 0.0079
87 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 3 0.0079
88 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
89 OXYGEN SATURATION 2 0.0076
90 SUBARACHNOID HAEMATOMA 1 0.0075
91 GASTROINTESTINAL MUCOSAL EXFOLIATION 1 0.0075
92 COLONIC PSEUDO-OBSTRUCTION 2 0.0072
93 CSF CELL COUNT INCREASED 1 0.0068
94 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
95 SPECIFIC GRAVITY URINE DECREASED 1 0.0065
96 NEUROLOGICAL EXAMINATION ABNORMAL 3 0.0064
97 ECHOLALIA 2 0.0063
98 NEPHROANGIOSCLEROSIS 1 0.0062
99 CONFUSIONAL AROUSAL 1 0.0062
100 HEPATIC CALCIFICATION 1 0.0061
101 PRINZMETAL ANGINA 6 0.0060
102 SCROTAL ERYTHEMA 1 0.0060
103 NERVE CONDUCTION STUDIES ABNORMAL 1 0.0060
104 HYPORESPONSIVE TO STIMULI 7 0.0060
105 PRODUCT CLOSURE REMOVAL DIFFICULT 6 0.0059
106 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
107 RECURRENCE OF NEUROMUSCULAR BLOCKADE 1 0.0058
108 PNEUMOPERICARDIUM 1 0.0058
109 HAEMOCONCENTRATION 1 0.0058
110 PROPOFOL INFUSION SYNDROME 4 0.0057
111 CARDIAC OUTPUT DECREASED 5 0.0057
112 DRUG-GENETIC INTERACTION 2 0.0056
113 ORAL DISCHARGE 2 0.0055
114 WEANING FAILURE 2 0.0055
115 LARYNGEAL OBSTRUCTION 1 0.0055
116 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0053
117 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0052
118 ATONIC URINARY BLADDER 1 0.0052
119 ALCOHOLIC PANCREATITIS 1 0.0051
120 SINOATRIAL BLOCK 3 0.0050
121 CATHETER SITE EXTRAVASATION 2 0.0050
122 SHIFT TO THE LEFT 1 0.0049
123 NEONATAL HYPOXIA 4 0.0048
124 LARYNGOSPASM 13 0.0048
125 PRODUCT ADMINISTRATION ISSUE 1 0.0048
126 ELECTROCARDIOGRAM PR SHORTENED 1 0.0048
127 REBOUND PSYCHOSIS 1 0.0047
128 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
129 MOYAMOYA DISEASE 1 0.0046
130 TORSADE DE POINTES 36 0.0046
131 RIGHT-TO-LEFT CARDIAC SHUNT 1 0.0045
132 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
133 RESPIRATORY FATIGUE 1 0.0043
134 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
135 ELECTROENCEPHALOGRAM ABNORMAL 13 0.0041
136 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
137 NODAL RHYTHM 6 0.0041
138 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
139 HYPERCALCIURIA 2 0.0041
140 ENTEROBACTER TEST POSITIVE 1 0.0041
141 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
142 NEONATAL SEIZURE 1 0.0040
143 METASTASES TO SOFT TISSUE 1 0.0039
144 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 3 0.0038
145 CULTURE WOUND POSITIVE 1 0.0038
146 HYPOTONIA NEONATAL 6 0.0038
147 HERPES ZOSTER REACTIVATION 1 0.0038
148 RESPIRATORY ACIDOSIS 15 0.0038
149 HYPERTHERMIA 29 0.0038
150 APNOEA 29 0.0037
151 PANCREATIC STEATOSIS 1 0.0037
152 CENTRAL NERVOUS SYSTEM NECROSIS 1 0.0036
153 BLOOD LACTIC ACID INCREASED 19 0.0036
154 ATRIOVENTRICULAR BLOCK COMPLETE 24 0.0036
155 POSTOPERATIVE FEVER 1 0.0036
156 BRADYCARDIA 189 0.0036
157 AGONAL RESPIRATION 1 0.0035
158 NODAL ARRHYTHMIA 3 0.0035
159 VASOCONSTRICTION 3 0.0034
160 ABDOMINAL MASS 9 0.0034
161 ANAESTHETIC COMPLICATION NEUROLOGICAL 3 0.0033
162 RESPIRATORY DEPRESSION 40 0.0033
163 HEPATIC ISCHAEMIA 1 0.0032
164 INCREASED DOSE ADMINISTERED 1 0.0032
165 SINUS BRADYCARDIA 31 0.0032
166 NEONATAL RESPIRATORY DISTRESS 3 0.0032
167 DEVICE PROGRAMMING ERROR 1 0.0032
168 BLADDER INJURY 1 0.0031
169 METABOLIC ALKALOSIS 5 0.0031
170 HYPERPYREXIA 13 0.0031
171 DIABETIC HYPERGLYCAEMIC COMA 1 0.0031
172 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
173 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
174 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
175 LARYNGOMALACIA 1 0.0030
176 WRONG PRODUCT ADMINISTERED 20 0.0030
177 FOETAL EXPOSURE DURING DELIVERY 2 0.0029
178 PRODUCT PACKAGING CONFUSION 7 0.0029
179 SJS-TEN OVERLAP 2 0.0028
180 HYPERNATRAEMIA 14 0.0028
181 CEREBRAL ARTERY OCCLUSION 3 0.0028
182 LIVIDITY 1 0.0027
183 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
184 THYROTOXIC CRISIS 3 0.0026
185 TRACHEITIS 2 0.0026
186 ELECTROCARDIOGRAM PR PROLONGATION 2 0.0026
187 BREATH HOLDING 1 0.0026
188 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
189 PRODUCT CONFUSION 2 0.0025
190 ELECTROMECHANICAL DISSOCIATION 2 0.0025
191 LONG QT SYNDROME 6 0.0025
192 LYMPHOCYTE STIMULATION TEST POSITIVE 2 0.0025
193 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
194 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
195 ARTERY DISSECTION 1 0.0024
196 SEIZURE CLUSTER 2 0.0024
197 CANDIDA TEST POSITIVE 1 0.0024
198 BRADYCARDIA NEONATAL 3 0.0024
199 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
200 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
201 APGAR SCORE LOW 3 0.0023
202 SLOW RESPONSE TO STIMULI 3 0.0023
203 SARCOPENIA 1 0.0023
204 HYPOTONIA 23 0.0023
205 VENTRICULAR FIBRILLATION 25 0.0022
206 HYPERLACTACIDAEMIA 6 0.0022
207 RESPIRATORY RATE DECREASED 7 0.0022
208 PROTEIN URINE 2 0.0022
209 POLYURIA 18 0.0022
210 LOCKED-IN SYNDROME 1 0.0022
211 CEREBRAL HYPOPERFUSION 1 0.0021
212 ENDOTRACHEAL INTUBATION 6 0.0021
213 MYOCLONUS 25 0.0021
214 PNEUMONIA HAEMOPHILUS 1 0.0021
215 MOTOR NEURONE DISEASE 1 0.0021
216 ELECTROLYTE DEPLETION 1 0.0020
217 GENERALISED TONIC-CLONIC SEIZURE 33 0.0020
218 HYPERCAPNIA 6 0.0020
219 SHUNT OCCLUSION 1 0.0020
220 HAEMODYNAMIC INSTABILITY 15 0.0020
221 BRUGADA SYNDROME 2 0.0019
222 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
223 STRESS CARDIOMYOPATHY 11 0.0019
224 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
225 ASTERIXIS 2 0.0019
226 JOINT CONTRACTURE 2 0.0019
227 EPIGLOTTITIS 1 0.0018
228 PRODUCT NAME CONFUSION 2 0.0018
229 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
230 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
231 ACCIDENT AT WORK 4 0.0018
232 PRODUCT CLOSURE ISSUE 1 0.0018
233 BLOOD FIBRINOGEN DECREASED 2 0.0018
234 FLASHBACK 1 0.0017
235 MEDIASTINITIS 1 0.0017
236 HYPERBILIRUBINAEMIA NEONATAL 1 0.0017
237 SINUS NODE DYSFUNCTION 3 0.0016
238 VENTRICULAR TACHYCARDIA 27 0.0016
239 INFUSION SITE WARMTH 2 0.0016
240 PARADOXICAL DRUG REACTION 6 0.0016
241 TACHYPNOEA 22 0.0016
242 DIAPHRAGMATIC HERNIA 1 0.0016
243 FOETAL HEART RATE DECREASED 1 0.0016
244 HYPOTHERMIA 16 0.0016
245 BRONCHIAL SECRETION RETENTION 2 0.0016
246 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
247 COMMUNICATION DISORDER 6 0.0016
248 CHOLINERGIC SYNDROME 1 0.0016
249 INCREASED BRONCHIAL SECRETION 4 0.0016
250 ENTEROCOCCUS TEST POSITIVE 1 0.0015
251 PROCEDURAL VOMITING 1 0.0015
252 KLEBSIELLA TEST POSITIVE 1 0.0015
253 HYPERAEMIA 3 0.0015
254 LUNG TRANSPLANT REJECTION 1 0.0015
255 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
256 BRADYPNOEA 4 0.0015
257 PARANEOPLASTIC SYNDROME 1 0.0015
258 CHOREOATHETOSIS 1 0.0015
259 CYTOKINE STORM 1 0.0015
260 ANASTOMOTIC LEAK 1 0.0014
261 HYPOPNOEA 5 0.0014
262 PEPTIC ULCER HAEMORRHAGE 1 0.0014
263 CRANIAL NERVE DISORDER 1 0.0014
264 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
265 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
266 DEVICE ELECTRICAL FINDING 1 0.0014
267 TONIC CONVULSION 2 0.0014
268 PORPHYRIA ACUTE 2 0.0014
269 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
270 CHYLOTHORAX 1 0.0014
271 AMNIOTIC CAVITY INFECTION 1 0.0014
272 GASTRIC MUCOSAL LESION 1 0.0014
273 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
274 DRUG-DISEASE INTERACTION 1 0.0014
275 STRIDOR 4 0.0014
276 CEREBRAL VASOCONSTRICTION 1 0.0014
277 INFUSION SITE INDURATION 2 0.0013
278 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
279 CARDIAC ARREST 111 0.0013
280 BLOOD PRESSURE IMMEASURABLE 2 0.0013
281 NEUROLOGICAL DECOMPENSATION 3 0.0013
282 CRITICAL ILLNESS 1 0.0013
283 BLOOD FIBRINOGEN INCREASED 1 0.0013
284 BRONCHOPULMONARY DYSPLASIA 1 0.0012
285 ENTEROCOCCAL SEPSIS 1 0.0012
286 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
287 RESPIRATORY ALKALOSIS 2 0.0012
288 FEAR OF FALLING 1 0.0012
289 PSEUDOMONAS TEST POSITIVE 1 0.0012
290 ACUTE PSYCHOSIS 3 0.0012
291 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
292 OESOPHAGEAL PERFORATION 1 0.0012
293 HYPERAMMONAEMIA 6 0.0012
294 INFUSION SITE OEDEMA 1 0.0012
295 ASPIRATION 13 0.0012
296 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
297 MALIGNANT HYPERTENSION 1 0.0012
298 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
299 OESOPHAGEAL OBSTRUCTION 1 0.0012
300 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
301 URINE OUTPUT INCREASED 3 0.0011
302 CEREBELLAR ATROPHY 1 0.0011
303 ENTEROCUTANEOUS FISTULA 1 0.0011
304 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
305 ILEUS 14 0.0011
306 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
307 MIOSIS 9 0.0011
308 CANDIDA SEPSIS 1 0.0011
309 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
310 ANEURYSM RUPTURED 1 0.0011
311 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
312 OXYGEN SATURATION DECREASED 60 0.0011
313 STEREOTYPY 1 0.0011
314 BRAIN STEM HAEMORRHAGE 1 0.0011
315 HEPATIC CONGESTION 1 0.0011
316 OXYGEN SATURATION ABNORMAL 3 0.0011
317 ELECTROCARDIOGRAM CHANGE 1 0.0011
318 CEREBRAL PALSY 1 0.0011
319 CARDIAC TAMPONADE 5 0.0011
320 PULSE ABSENT 5 0.0011
321 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
322 AGITATION NEONATAL 1 0.0010
323 ATRIOVENTRICULAR BLOCK 8 0.0010
324 BLADDER CATHETERISATION 1 0.0010
325 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
326 WITHDRAWAL SYNDROME 43 0.0010
327 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
328 EYE MOVEMENT DISORDER 7 0.0010
329 IDIOSYNCRATIC DRUG REACTION 1 0.0010
330 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
331 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
332 MUCOSAL DRYNESS 2 0.0010
333 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
334 HYPERTENSIVE CRISIS 11 0.0010
335 DRUG TOLERANCE 5 0.0010
336 DYSPHORIA 5 0.0010
337 HYPOCHROMIC ANAEMIA 1 0.0010
338 TOXIC ENCEPHALOPATHY 5 0.0010
339 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
340 QUADRIPLEGIA 2 0.0010
341 SUBILEUS 2 0.0010
342 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
343 DEVICE INEFFECTIVE 1 0.0009
344 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
345 OCULOGYRIC CRISIS 2 0.0009
346 ATELECTASIS 9 0.0009
347 HYPERPHOSPHATAEMIA 2 0.0009
348 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
349 HYPOVENTILATION 3 0.0009
350 CARDIAC HYPERTROPHY 1 0.0009
351 HEART RATE ABNORMAL 5 0.0009
352 ILEUS PARALYTIC 4 0.0009
353 ANAPHYLACTIC SHOCK 23 0.0009
354 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
355 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
356 SUSPECTED OFF LABEL USE 4 0.0009
357 KOUNIS SYNDROME 2 0.0009
358 ACCIDENTAL OVERDOSE 32 0.0009
359 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
360 PAROTITIS 1 0.0009
361 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
362 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
363 ACUTE LUNG INJURY 1 0.0008
364 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
365 CHRONIC RESPIRATORY FAILURE 1 0.0008
366 BLEEDING TIME PROLONGED 1 0.0008
367 STARING 2 0.0008
368 PHARYNGEAL HAEMORRHAGE 1 0.0008
369 HYPOXIA 28 0.0008
370 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
371 MYOCARDIAL ISCHAEMIA 9 0.0008
372 BLOOD BILIRUBIN ABNORMAL 1 0.0008
373 DELIRIUM 27 0.0008
374 SINUS TACHYCARDIA 11 0.0008
375 THERAPY PARTIAL RESPONDER 12 0.0008
376 SINUS ARRHYTHMIA 1 0.0008
377 CARDIOGENIC SHOCK 11 0.0008
378 DRUG CLEARANCE DECREASED 1 0.0008
379 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
380 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
381 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
382 EXTRAVASATION 3 0.0007
383 INFUSION SITE RASH 1 0.0007
384 RED BLOOD CELL COUNT INCREASED 2 0.0007
385 ECHOCARDIOGRAM ABNORMAL 1 0.0007
386 H1N1 INFLUENZA 1 0.0007
387 CULTURE URINE POSITIVE 1 0.0007
388 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
389 CHOLECYSTITIS ACUTE 4 0.0007
390 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
391 CIRCULATORY COLLAPSE 12 0.0007
392 HYPERVENTILATION 4 0.0007
393 HAEMOTHORAX 2 0.0007
394 PRODUCT LABEL CONFUSION 4 0.0007
395 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
396 CEREBRAL DISORDER 5 0.0007
397 VENTRICULAR EXTRASYSTOLES 7 0.0007
398 AGITATION 49 0.0007
399 MIXED LIVER INJURY 2 0.0007
400 EMBOLISM VENOUS 2 0.0007
401 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
402 ACIDOSIS 5 0.0007
403 MYOGLOBIN BLOOD INCREASED 1 0.0007
404 RHABDOMYOLYSIS 27 0.0006
405 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
406 ANTICHOLINERGIC SYNDROME 1 0.0006
407 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
408 DISINHIBITION 1 0.0006
409 SEDATION 16 0.0006
410 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
411 PNEUMONIA ASPIRATION 15 0.0006
412 GAZE PALSY 1 0.0006
413 WOUND COMPLICATION 2 0.0006
414 UNRESPONSIVE TO STIMULI 15 0.0006
415 SHOCK 13 0.0006
416 MITRAL VALVE DISEASE 1 0.0006
417 FIBRIN D DIMER INCREASED 2 0.0006
418 PARAPARESIS 1 0.0006
419 GRAFT VERSUS HOST DISEASE 4 0.0006
420 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
421 PNEUMOMEDIASTINUM 1 0.0006
422 DEVICE ALARM ISSUE 1 0.0006
423 HYPERGLYCAEMIA 20 0.0005
424 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
425 CONDUCTION DISORDER 1 0.0005
426 DRUG LEVEL INCREASED 9 0.0005
427 AMYLASE INCREASED 2 0.0005
428 PUPILLARY REFLEX IMPAIRED 1 0.0005
429 MENTAL STATUS CHANGES 15 0.0005
430 CATHETER PLACEMENT 1 0.0005
431 LYMPH NODE PAIN 1 0.0005
432 LEUKOENCEPHALOPATHY 2 0.0005
433 RESPIRATORY FAILURE 39 0.0005
434 ACUTE PULMONARY OEDEMA 3 0.0005
435 ADENOCARCINOMA OF COLON 1 0.0005
436 STENOSIS 1 0.0005
437 JAUNDICE NEONATAL 1 0.0005
438 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
439 MECHANICAL VENTILATION 1 0.0005
440 HYPERCOAGULATION 1 0.0005
441 PROCEDURAL COMPLICATION 4 0.0005
442 CHOLESTASIS 10 0.0005
443 ELECTROLYTE IMBALANCE 6 0.0005
444 CARDIOPULMONARY FAILURE 2 0.0005
445 HEART RATE DECREASED 18 0.0005
446 MULTI-ORGAN DISORDER 1 0.0005
447 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
448 TACHYCARDIA 43 0.0005
449 LIVEDO RETICULARIS 1 0.0005
450 HYPOTENSION 96 0.0005
451 LUNG ABSCESS 1 0.0005
452 ATRIAL TACHYCARDIA 1 0.0005
453 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
454 RESPIRATORY ARREST 13 0.0005
455 RESPIRATORY DISTRESS 13 0.0005
456 RADIATION PNEUMONITIS 1 0.0005
457 CATHETER SITE ERYTHEMA 1 0.0005
458 BLOOD PRESSURE DECREASED 31 0.0005
459 SEPTIC SHOCK 20 0.0005
460 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
461 CARDIO-RESPIRATORY ARREST 19 0.0005
462 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
463 DRUG INTERACTION 72 0.0005
464 CLOSTRIDIUM TEST POSITIVE 1 0.0005
465 CARDIAC FAILURE ACUTE 3 0.0004
466 CEREBRAL INFARCTION 11 0.0004
467 STATUS EPILEPTICUS 5 0.0004
468 METASTASES TO MENINGES 1 0.0004
469 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
470 RESPIRATION ABNORMAL 3 0.0004
471 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
472 BILIRUBIN CONJUGATED INCREASED 1 0.0004
473 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
474 LACERATION 4 0.0004
475 CONTRAST MEDIA REACTION 1 0.0004
476 HYPOVOLAEMIC SHOCK 2 0.0004
477 THROMBOTIC MICROANGIOPATHY 4 0.0004
478 ENCEPHALOPATHY 10 0.0004
479 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
480 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
481 CORONARY ARTERY STENOSIS 2 0.0004
482 EXCORIATION 1 0.0004
483 HEPATIC CYTOLYSIS 5 0.0004
484 ANGLE CLOSURE GLAUCOMA 1 0.0004
485 ABDOMINAL INFECTION 1 0.0004
486 FEMORAL NECK FRACTURE 2 0.0004
487 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
488 MALABSORPTION 2 0.0004
489 APLASTIC ANAEMIA 2 0.0004
490 PARTIAL SEIZURES 2 0.0004
491 HYPERSENSITIVITY VASCULITIS 1 0.0004
492 CATATONIA 2 0.0004
493 RADICULOPATHY 1 0.0004
494 ATRIAL FLUTTER 3 0.0004
495 ALCOHOL POISONING 1 0.0004
496 ANAESTHETIC COMPLICATION 1 0.0004
497 BLOOD SODIUM INCREASED 1 0.0004
498 HICCUPS 3 0.0004
499 PRODUCT USE IN UNAPPROVED INDICATION 90 0.0004
500 IMMUNE-MEDIATED MYOSITIS 1 0.0004
501 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
502 RASH MORBILLIFORM 1 0.0004
503 MACULE 1 0.0004
504 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
505 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
506 DRUG WITHDRAWAL SYNDROME 31 0.0004
507 HEPATOCELLULAR INJURY 5 0.0004
508 RESPIRATORY SYMPTOM 1 0.0004
509 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
510 ADENOVIRUS INFECTION 1 0.0003
511 METABOLIC ACIDOSIS 11 0.0003
512 URINE OUTPUT DECREASED 3 0.0003
513 DEVICE POWER SOURCE ISSUE 1 0.0003
514 BACTERAEMIA 4 0.0003
515 HEPATITIS FULMINANT 1 0.0003
516 BRAIN HERNIATION 1 0.0003
517 INFUSION SITE REACTION 1 0.0003
518 HAEMORRHAGE INTRACRANIAL 5 0.0003
519 PROTHROMBIN TIME PROLONGED 2 0.0003
520 METABOLIC ENCEPHALOPATHY 1 0.0003
521 FOETAL GROWTH RESTRICTION 2 0.0003
522 RESTLESSNESS 12 0.0003
523 DIASTOLIC DYSFUNCTION 1 0.0003
524 INFUSION SITE SWELLING 2 0.0003
525 HYPOCALCAEMIA 6 0.0003
526 PRODUCT USE ISSUE 59 0.0003
527 ACUTE RESPIRATORY FAILURE 6 0.0003
528 SKIN EROSION 1 0.0003
529 DYSTONIA 6 0.0003
530 FEBRILE NEUTROPENIA 20 0.0003
531 MENINGITIS 2 0.0003
532 PROSTATE CANCER METASTATIC 1 0.0003
533 BLOOD UREA INCREASED 5 0.0003
534 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
535 POTENTIATING DRUG INTERACTION 1 0.0003
536 PRODUCT ADMINISTRATION ERROR 6 0.0003
537 SUBARACHNOID HAEMORRHAGE 3 0.0003
538 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
539 BODY TEMPERATURE INCREASED 6 0.0003
540 BRONCHOPNEUMONIA 1 0.0003
541 BLOOD PRESSURE FLUCTUATION 7 0.0003
542 LEFT VENTRICULAR FAILURE 1 0.0003
543 DROOLING 2 0.0003
544 DRUG-INDUCED LIVER INJURY 9 0.0003
545 BRONCHIOLITIS 1 0.0003
546 JAUNDICE CHOLESTATIC 1 0.0003
547 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
548 FACIAL PARESIS 1 0.0003
549 HYPOKALAEMIA 13 0.0003
550 HAEMORRHAGIC DIATHESIS 1 0.0003
551 CONJUNCTIVAL HYPERAEMIA 1 0.0003
552 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
553 APPARENT DEATH 1 0.0003
554 RESTLESS LEGS SYNDROME 5 0.0003
555 CAROTID ARTERY OCCLUSION 1 0.0003
556 CUTANEOUS VASCULITIS 1 0.0003
557 MOUTH HAEMORRHAGE 2 0.0003
558 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
559 DYSKINESIA 11 0.0003
560 CARDIAC DYSFUNCTION 1 0.0003
561 PROTEIN TOTAL DECREASED 1 0.0003
562 REBOUND EFFECT 3 0.0003
563 CATHETER SITE INFECTION 1 0.0003
564 OESOPHAGEAL ULCER 1 0.0003
565 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
566 PROCEDURAL HAEMORRHAGE 1 0.0003
567 TOXICITY TO VARIOUS AGENTS 43 0.0003
568 COVID-19 PNEUMONIA 3 0.0003
569 BLOOD ALBUMIN DECREASED 2 0.0003
570 PATENT DUCTUS ARTERIOSUS 1 0.0003
571 LOW BIRTH WEIGHT BABY 2 0.0003
572 CEREBRAL ATROPHY 1 0.0003
573 MUSCLE RIGIDITY 3 0.0003
574 SYNCOPE 25 0.0002
575 IRRITABILITY 15 0.0002
576 CANDIDIASIS 1 0.0002
577 MYASTHENIA GRAVIS 2 0.0002
578 HYPERAESTHESIA 2 0.0002
579 HYPERURICAEMIA 1 0.0002
580 ANAPHYLACTOID REACTION 1 0.0002
581 EXTRAPYRAMIDAL DISORDER 6 0.0002
582 INFUSION SITE ERYTHEMA 2 0.0002
583 ANAPHYLACTIC REACTION 13 0.0002
584 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
585 ANURIA 2 0.0002
586 MULTI-ORGAN FAILURE 4 0.0002
587 MONOPLEGIA 1 0.0002
588 PULMONARY CONGESTION 3 0.0002
589 ABDOMINAL ABSCESS 1 0.0002
590 PURPURA 2 0.0002
591 SEIZURE 26 0.0002
592 HAEMOGLOBIN INCREASED 1 0.0002
593 LOSS OF CONSCIOUSNESS 28 0.0002
594 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
595 ISCHAEMIA 1 0.0002
596 INTERCEPTED MEDICATION ERROR 1 0.0002
597 SEPSIS 24 0.0002
598 HEPATIC FUNCTION ABNORMAL 8 0.0002
599 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
600 SEROTONIN SYNDROME 4 0.0002
601 RENAL CELL CARCINOMA 1 0.0002
602 HEPATOMEGALY 2 0.0002
603 STAPHYLOCOCCAL SEPSIS 1 0.0002
604 PYREXIA 70 0.0002
605 INFLAMMATORY MARKER INCREASED 1 0.0002
606 RESPIRATORY DISORDER 6 0.0002
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
608 SALIVARY HYPERSECRETION 2 0.0002
609 BRAIN INJURY 2 0.0002
610 PREMATURE BABY 6 0.0002
611 OVERDOSE 43 0.0002
612 PATHOLOGICAL FRACTURE 1 0.0002
613 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
614 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
615 CACHEXIA 1 0.0002
616 LUNG INFECTION 3 0.0002
617 HYPERBILIRUBINAEMIA 2 0.0002
618 SKIN NECROSIS 1 0.0002
619 SERUM FERRITIN INCREASED 1 0.0002
620 SOMNOLENCE 38 0.0002
621 INTERSTITIAL LUNG DISEASE 9 0.0002
622 ATRIAL FIBRILLATION 18 0.0002
623 HYDROCEPHALUS 1 0.0002
624 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
625 INTESTINAL ISCHAEMIA 1 0.0002
626 GASTRIC ULCER HAEMORRHAGE 1 0.0002
627 INTRACRANIAL PRESSURE INCREASED 1 0.0002
628 OFF LABEL USE 157 0.0002
629 PULMONARY OEDEMA 8 0.0002
630 INTESTINAL PERFORATION 2 0.0002
631 GENERALISED ERYTHEMA 1 0.0002
632 CORONARY ARTERY BYPASS 1 0.0002
633 GASTRIC HAEMORRHAGE 2 0.0002
634 RALES 1 0.0002
635 METABOLIC DISORDER 1 0.0002
636 ACUTE KIDNEY INJURY 26 0.0002
637 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
638 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
639 ATAXIA 2 0.0002
640 PLEURISY 1 0.0002
641 COMA 8 0.0002
642 ADRENAL INSUFFICIENCY 2 0.0002
643 DERMATITIS ACNEIFORM 1 0.0002
644 NO THERAPEUTIC RESPONSE 2 0.0002
645 EPILEPSY 5 0.0002
646 LARYNGEAL OEDEMA 1 0.0002
647 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
648 HYPERCALCAEMIA 2 0.0002
649 OLIGURIA 1 0.0002
650 INFUSION SITE EXTRAVASATION 1 0.0002
651 PROCTALGIA 1 0.0002
652 HEPATITIS ACUTE 1 0.0002
653 ANGINA UNSTABLE 1 0.0002
654 PLATELET COUNT INCREASED 2 0.0002
655 HYPOGAMMAGLOBULINAEMIA 1 0.0002
656 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
657 PLATELET COUNT DECREASED 16 0.0001
658 POST-TRAUMATIC STRESS DISORDER 1 0.0001
659 COLITIS ISCHAEMIC 1 0.0001
660 BLOOD BILIRUBIN INCREASED 4 0.0001
661 PLEURAL EFFUSION 9 0.0001
662 IMPAIRED GASTRIC EMPTYING 2 0.0001
663 ABNORMAL LOSS OF WEIGHT 1 0.0001
664 ACUTE HEPATIC FAILURE 2 0.0001
665 ENCEPHALITIS 1 0.0001
666 AUTOIMMUNE HEPATITIS 1 0.0001
667 HYPOMAGNESAEMIA 2 0.0001
668 COORDINATION ABNORMAL 2 0.0001
669 PAPULE 1 0.0001
670 DUODENAL ULCER 1 0.0001
671 HYPERTENSION 30 0.0001
672 METASTASIS 1 0.0001
673 AGGRESSION 7 0.0001
674 LIVER FUNCTION TEST INCREASED 3 0.0001
675 DERMATITIS BULLOUS 1 0.0001
676 C-REACTIVE PROTEIN INCREASED 5 0.0001
677 MELAENA 3 0.0001
678 CARDIOMYOPATHY 2 0.0001
679 HYPOPHOSPHATAEMIA 1 0.0001
680 LIVER DISORDER 6 0.0001
681 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
682 DYSARTHRIA 5 0.0001
683 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
684 HAEMOLYSIS 1 0.0001
685 CONCUSSION 1 0.0001
686 HYPOALBUMINAEMIA 1 0.0001
687 COGNITIVE DISORDER 6 0.0001
688 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
689 CYANOSIS 2 0.0001
690 ARRHYTHMIA 6 0.0001
691 DRUG SCREEN POSITIVE 1 0.0001
692 PNEUMOTHORAX 2 0.0001
693 RENAL CYST 1 0.0001
694 BLOOD DISORDER 1 0.0001
695 MUSCLE TIGHTNESS 2 0.0001
696 POST PROCEDURAL INFECTION 1 0.0001
697 SHOCK HAEMORRHAGIC 1 0.0001
698 DECUBITUS ULCER 1 0.0001
699 NEUTROPHIL COUNT DECREASED 5 0.0001
700 ACUTE CORONARY SYNDROME 1 0.0001
701 COAGULOPATHY 2 0.0001
702 EOSINOPHIL COUNT INCREASED 1 0.0001
703 RENAL IMPAIRMENT 10 0.0001
704 PRODUCT COMPLAINT 3 0.0001
705 HEMIPARESIS 2 0.0001
706 INADEQUATE ANALGESIA 1 0.0001
707 SCAR 2 0.0001
708 PRODUCT CONTAINER ISSUE 1 0.0001
709 NEUROTOXICITY 2 0.0001
710 EOSINOPHILIA 2 0.0001
711 CARDIOTOXICITY 1 0.0001
712 CEREBRAL HAEMORRHAGE 4 0.0001
713 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
714 OROPHARYNGEAL DISCOMFORT 1 0.0001
715 PALLOR 3 0.0001
716 PNEUMONITIS 3 0.0001
717 MOOD ALTERED 3 0.0001
718 PNEUMONIA 35 0.0001
719 BLOOD CREATININE INCREASED 7 0.0001
720 ARTERIOSCLEROSIS 1 0.0001
721 PROTEINURIA 2 0.0001
722 RED BLOOD CELL COUNT DECREASED 3 0.0001
723 LETHARGY 6 0.0001
724 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
725 ACUTE MYOCARDIAL INFARCTION 3 0.0001
726 BODY TEMPERATURE DECREASED 1 0.0001
727 DISEASE PROGRESSION 12 0.0001
728 DISORIENTATION 4 0.0001
729 HAEMATOCRIT DECREASED 2 0.0001
730 APHASIA 3 0.0001
731 MOTOR DYSFUNCTION 1 0.0001
732 RENAL FAILURE 13 0.0001
733 NEUTROPHIL COUNT INCREASED 1 0.0001
734 INITIAL INSOMNIA 1 0.0001
735 EAR DISCOMFORT 1 0.0001
736 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
737 EYE DISCHARGE 1 0.0001
738 INTENTIONAL DRUG MISUSE 2 0.0001
739 ANAEMIA 18 0.0001
740 BREAST CANCER METASTATIC 1 0.0001
741 DECREASED ACTIVITY 1 0.0001
742 FAECES DISCOLOURED 2 0.0001
743 PRODUCT PRESCRIBING ISSUE 2 0.0001
744 HEART RATE INCREASED 9 0.0001
745 STEVENS-JOHNSON SYNDROME 2 0.0001
746 RASH MACULO-PAPULAR 2 0.0001
747 RASH PAPULAR 2 0.0001
748 NEPHROPATHY TOXIC 1 0.0001
749 BLOOD CALCIUM DECREASED 1 0.0001
750 HEART RATE IRREGULAR 2 0.0001
751 MICTURITION URGENCY 1 0.0001
752 CHOLECYSTECTOMY 1 0.0001
753 CARDIAC FAILURE 7 0.0001
754 METASTASES TO LUNG 1 0.0001
755 PERICARDIAL EFFUSION 2 0.0001
756 POST PROCEDURAL HAEMORRHAGE 1 0.0001
757 CAESAREAN SECTION 1 0.0001
758 HYPERKALAEMIA 3 0.0001
759 COMPLETED SUICIDE 7 0.0001
760 PRODUCT PRESCRIBING ERROR 2 0.0001
761 RASH ERYTHEMATOUS 4 0.0001
762 HYPOGLYCAEMIA 4 0.0001
763 LIVER INJURY 2 0.0001
764 CARDIOMEGALY 1 0.0001
765 INJECTION SITE EXTRAVASATION 1 0.0001
766 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
767 LEUKOPENIA 4 0.0001
768 MUSCULOSKELETAL STIFFNESS 7 0.0001
769 POISONING 1 0.0001
770 UNEVALUABLE EVENT 6 0.0001
771 MYDRIASIS 1 0.0001
772 HAEMOGLOBIN DECREASED 8 0.0001
773 INFUSION SITE PAIN 1 0.0001
774 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
775 HIATUS HERNIA 1 0.0001
776 HAEMATOMA 2 0.0001
777 MUCOSAL INFLAMMATION 2 0.0001
778 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
779 PANCREATITIS 4 0.0001
780 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
781 QUALITY OF LIFE DECREASED 1 0.0001
782 OEDEMA 4 0.0001
783 DYSPHAGIA 7 0.0001
784 PULMONARY EMBOLISM 7 0.0001
785 SKIN LESION 2 0.0001
786 PROCEDURAL PAIN 2 0.0001
787 BLISTER 4 0.0001
788 RENAL FAILURE ACUTE 3 0.0001
789 DIALYSIS 1 0.0001
790 BRONCHOSPASM 1 0.0001
791 PARALYSIS 1 0.0001
792 HYPERSOMNIA 2 0.0001
793 PARAESTHESIA ORAL 1 0.0001
794 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
795 LIVER FUNCTION TEST ABNORMAL 2 0.0001
796 GASTROENTERITIS 1 0.0001
797 ANGIOEDEMA 3 0.0001
798 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
799 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
800 THERAPY NON-RESPONDER 3 0.0001
801 HYPOAESTHESIA ORAL 1 0.0001
802 DISCOMFORT 4 0.0001
803 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
804 DEVICE RELATED INFECTION 1 0.0001
805 HYPERSENSITIVITY 12 0.0001
806 ACUTE MYELOID LEUKAEMIA 1 0.0001
807 VOMITING 30 0.0001
808 PREMATURE DELIVERY 1 0.0001
809 OBESITY 1 0.0001
810 CONDITION AGGRAVATED 19 0.0001
811 INTENTIONAL OVERDOSE 4 0.0001
812 SENSORY DISTURBANCE 1 0.0001
813 MOVEMENT DISORDER 2 0.0001
814 INFECTION 9 0.0001
815 DEEP VEIN THROMBOSIS 4 0.0001
816 METASTASES TO BONE 1 0.0001
817 INFUSION RELATED REACTION 4 0.0001
818 CYTOMEGALOVIRUS INFECTION 1 0.0001
819 FUNGAL INFECTION 2 0.0001
820 URINARY RETENTION 2 0.0001
821 CONSTIPATION 13 0.0001
822 FACE OEDEMA 1 0.0001
823 CANDIDA INFECTION 1 0.0001
824 HEPATIC ENZYME INCREASED 4 0.0001
825 HAEMATURIA 2 0.0001
826 DYSPNOEA 33 0.0001
827 NEOPLASM PROGRESSION 2 0.0001
828 ORTHOSTATIC HYPOTENSION 1 0.0001
829 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
830 LYMPHADENOPATHY 2 0.0001
831 DRUG ERUPTION 1 0.0001
832 ISCHAEMIC STROKE 1 0.0001
833 NO ADVERSE EVENT 10 0.0001
834 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
835 PELVIC PAIN 1 0.0001
836 CRYING 2 0.0001
837 TREMOR 9 0.0001
838 AGRANULOCYTOSIS 1 0.0001
839 PANCYTOPENIA 3 0.0001
840 THROMBOCYTOPENIA 6 0.0001
841 BACTERIAL INFECTION 1 0.0001
842 MIDDLE INSOMNIA 1 0.0001
843 HYPONATRAEMIA 3 0.0001
844 CEREBROVASCULAR ACCIDENT 9 0.0001
845 HALLUCINATION 4 0.0001
846 CONVULSION 3 0.0001
847 SLEEP APNOEA SYNDROME 1 0.0001
848 POST PROCEDURAL COMPLICATION 1 0.0001
849 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
850 PRESCRIBED OVERDOSE 1 0.0001
851 ORAL HERPES 1 0.0001
852 SINUS DISORDER 1 0.0001
853 BLOOD PRESSURE ABNORMAL 1 0.0001
854 CYTOKINE RELEASE SYNDROME 1 0.0000
855 CONFUSIONAL STATE 8 0.0000
856 STOMATITIS 3 0.0000
857 BONE MARROW FAILURE 1 0.0000
858 PRODUCT PREPARATION ERROR 1 0.0000
859 RIB FRACTURE 1 0.0000
860 PERITONITIS 1 0.0000
861 TREATMENT FAILURE 4 0.0000
862 EXPOSURE DURING PREGNANCY 3 0.0000
863 PULMONARY HYPERTENSION 1 0.0000
864 HAEMORRHAGE 5 0.0000
865 URTICARIA 8 0.0000
866 DERMATITIS 1 0.0000
867 EATING DISORDER 1 0.0000
868 POOR QUALITY SLEEP 1 0.0000
869 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
870 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
871 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
872 DRUG INEFFECTIVE 59 0.0000
873 MUSCULAR WEAKNESS 5 0.0000
874 SLEEP DISORDER 3 0.0000
875 DIABETIC KETOACIDOSIS 1 0.0000
876 PRESYNCOPE 1 0.0000
877 UNDERDOSE 3 0.0000
878 ABASIA 1 0.0000
879 THERAPY CESSATION 2 0.0000
880 DRUG RESISTANCE 1 0.0000
881 RESPIRATORY TRACT INFECTION 1 0.0000
882 ABDOMINAL DISTENSION 4 0.0000
883 FEAR 1 0.0000
884 JAUNDICE 1 0.0000
885 DISTURBANCE IN ATTENTION 2 0.0000
886 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
887 MEDICATION ERROR 2 0.0000
888 HAEMOPTYSIS 1 0.0000
889 HERPES ZOSTER 2 0.0000
890 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
891 ASCITES 1 0.0000
892 PSYCHOTIC DISORDER 1 0.0000
893 HEPATIC FAILURE 1 0.0000
894 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
895 OEDEMA PERIPHERAL 4 0.0000
896 VERTIGO 2 0.0000
897 BLOOD PRESSURE INCREASED 5 0.0000
898 EMOTIONAL DISORDER 1 0.0000
899 FEMUR FRACTURE 1 0.0000
900 HEAD INJURY 1 0.0000
901 HYPOTHYROIDISM 1 0.0000
902 DRUG DEPENDENCE 5 0.0000
903 RHINORRHOEA 2 0.0000
904 LACTIC ACIDOSIS 1 0.0000
905 AMNESIA 2 0.0000
906 EYE DISORDER 1 0.0000
907 NAUSEA 24 0.0000
908 STAPHYLOCOCCAL INFECTION 1 0.0000
909 DEHYDRATION 4 0.0000
910 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
911 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
912 ERYTHEMA 6 0.0000
913 INJURY 2 0.0000
914 ANXIETY 8 0.0000
915 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
916 RASH 12 0.0000
917 EPISTAXIS 2 0.0000
918 INTESTINAL OBSTRUCTION 1 0.0000
919 CHRONIC KIDNEY DISEASE 2 0.0000
920 PALPITATIONS 3 0.0000
921 ABNORMAL BEHAVIOUR 1 0.0000
922 THROMBOSIS 2 0.0000
923 LUNG NEOPLASM MALIGNANT 1 0.0000
924 SKIN EXFOLIATION 2 0.0000
925 HYPERHIDROSIS 3 0.0000
926 DIARRHOEA 15 0.0000
927 DEATH 20 0.0000
928 DEVICE LEAKAGE 1 0.0000
929 MENTAL DISORDER 1 0.0000
930 COVID-19 4 0.0000
931 PAIN 14 0.0000
932 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
933 NEUTROPENIA 3 0.0000
934 SKIN DISCOLOURATION 1 0.0000
935 RENAL DISORDER 1 0.0000
936 SWELLING 2 0.0000
937 DISEASE RECURRENCE 1 0.0000
938 BLOOD GLUCOSE DECREASED 1 0.0000
939 DRUG INTOLERANCE 2 0.0000
940 FLUSHING 2 0.0000
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
942 SPEECH DISORDER 1 0.0000
943 DEPRESSED MOOD 1 0.0000
944 RASH PRURITIC 1 0.0000
945 HAEMATOCHEZIA 1 0.0000
946 INFLUENZA 2 0.0000
947 COUGH 5 0.0000
948 ASTHMA 2 0.0000
949 URINARY TRACT INFECTION 3 0.0000
950 BONE PAIN 1 0.0000
951 CHILLS 2 0.0000
952 FEELING ABNORMAL 4 0.0000
953 JOINT SWELLING 2 0.0000
954 MUSCLE SPASMS 3 0.0000
955 CHEST PAIN 3 0.0000
956 GAIT DISTURBANCE 3 0.0000
957 INSOMNIA 4 0.0000
958 NEOPLASM MALIGNANT 1 0.0000
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
960 SKIN BURNING SENSATION 1 0.0000
961 MOBILITY DECREASED 1 0.0000
962 HYPOAESTHESIA 2 0.0000
963 INCORRECT DOSE ADMINISTERED 3 0.0000
964 PRURITUS 5 0.0000
965 CARDIAC FAILURE CONGESTIVE 1 0.0000
966 DRY MOUTH 1 0.0000
967 DIZZINESS 6 0.0000
968 DRUG ABUSE 1 0.0000
969 MYOCARDIAL INFARCTION 2 0.0000
970 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
971 DEVICE ISSUE 1 0.0000
972 NASOPHARYNGITIS 2 0.0000
973 BLOOD GLUCOSE INCREASED 2 0.0000
974 CONTUSION 1 0.0000
975 FATIGUE 8 0.0000
976 SINUSITIS 1 0.0000
977 FALL 3 0.0000
978 ABDOMINAL PAIN 2 0.0000
979 INJECTION SITE ERYTHEMA 1 0.0000
980 ASTHENIA 3 0.0000
981 HEADACHE 5 0.0000
982 DRY SKIN 1 0.0000
983 PARAESTHESIA 1 0.0000
984 ABDOMINAL DISCOMFORT 1 0.0000
985 ABDOMINAL PAIN UPPER 1 0.0000
986 DEPRESSION 1 0.0000
987 PRODUCT DOSE OMISSION ISSUE 1 0.0000
988 PAIN IN EXTREMITY 1 0.0000
989 INJECTION SITE PAIN 1 0.0000
990 ARTHRALGIA 1 0.0000
991 MALAISE 1 0.0000